Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2013
10/01/2013US8546319 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
10/01/2013US8546118 Aldolases, nucleic acids encoding them and methods for making and using them
10/01/2013US8546107 Epidermal growth factor receptor mutations
10/01/2013US8546106 Methods of increasing secretion of polypeptides having biological activity
10/01/2013US8546105 Engineering intracellular sialylation pathways
10/01/2013US8545847 Human antibodies to the human glucagon receptor and methods of use thereof
10/01/2013US8545844 Humanized antibodies against human IL-22RA
10/01/2013US8545842 Polynucleotides encoding IL-17 receptor A antigen binding proteins
10/01/2013CA2657040C Improved process for the culturing of cells
10/01/2013CA2558612C Method and antibodies for detecting milk allergens
10/01/2013CA2551008C Anti-cd40 antibody mutants
10/01/2013CA2516520C N-acetylglucosaminyltransferase iii expression in lower eukaryotes
10/01/2013CA2408038C Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
10/01/2013CA2366520C Anti-bacterial vaccine compositions
10/01/2013CA2239448C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/2013
09/26/2013WO2013141823A1 Modified bordetella pertussis strains
09/26/2013WO2013028635A9 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
09/26/2013US20130253176 Host cells comprising alpha 1, 2 mannosidase and culture methods thereof
09/26/2013US20130252877 Method for preparing active peptides from corn germ proteins
09/26/2013US20130252840 Liquid tissue preparation from histopathologically processed biologically samples, tissues and cells
09/26/2013US20130252829 Parallel Methods For Insertional Mutagenesis
09/26/2013US20130252310 Novel aldolase and production process of substituted alpha-keto acids
09/26/2013US20130252281 Formulation and delivery of plga microspheres
09/26/2013US20130251658 Hydrophobized protein hydrolysate
09/25/2013EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same
09/25/2013EP2640842A1 Methods and compositions for inducing an immune response to egfrviii
09/25/2013EP2640841A1 Method of producing lipidated polypeptides
09/25/2013EP2640751A1 Lipidated polyepitope vaccines
09/25/2013EP2640421A1 Regimens for treatments using anti-igf antibodies
09/25/2013EP2640405A2 Human-adapted ha polypeptides, vaccines, and influenza treatment
09/25/2013EP2520589A9 Anti-cd27 antibody
09/25/2013CN103328649A Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
09/25/2013CN103328648A Peptide with safer secondary structure, peptide library, and production methods for same
09/25/2013CN103328647A Recombinant flaviviral constructs and uses thereof
09/25/2013CN103328646A Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
09/25/2013CN103328632A Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
09/25/2013CN103328509A Method for measuring human insulin and measurement reagent
09/25/2013CN103320489A Pine nut protein source anti-oxidation peptide and preparation method thereof
09/25/2013CN103320488A Method for preparing ACE (Angiotensin Converting Enzyme) inhibitory peptides through proteolysis of eucommia seed cakes
09/25/2013CN103320487A Method for preparing trepang peptide by combined hydrolysis of soluble enzyme and immobilized enzyme
09/25/2013CN103320486A Method for producing chondroitin sulfate with coproduction of hydrolyzed collagen by employing fish cartilage
09/25/2013CN103320485A Preparation method of fish-skin collagen for medical biomaterial
09/25/2013CN103320461A Method for constitutive expression of target antibacterial peptide AgPlectasin in Pichia pastoris
09/25/2013CN103320447A Recombinant human interleukin 4 gene, and fermentation method of engineering bacteria comprising recombinant human interleukin 4 gene
09/25/2013CN103319610A Novel recombinant fusion protein, preparation method and use thereof
09/25/2013CN103319596A Compositions and methods for increasing bone mineralization
09/25/2013CN103319595A Preparation method and application of anti-human alpha fetoprotein (AFP) single-chain antibody and fusion antigen peptide
09/25/2013CN102250998B Preparation method for peanut bioactive peptide
09/24/2013US8541655 Transgenic plants expressing modified Cry3A
09/24/2013US8541565 Polynucleotide encoding anti-CD14 antibody fusion protein
09/24/2013US8541564 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
09/24/2013US8541558 Fluorescent proteins and uses thereof
09/24/2013US8541552 Antibodies to lymphotoxin-α
09/24/2013US8541550 Methods and compositions for delivering polynucleotides
09/24/2013US8541236 Oxidation resistant mutant apoA-I polypeptide having a combination of: a conservative amino acid substitution at residue Tyr192; and at least one conservative amino acid substitution at residue Met86, Met112, or Met148; promoting cholesterol efflux; atherosclerosis
09/24/2013US8541230 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
09/24/2013US8541204 Polypeptide producing cells
09/24/2013US8541203 Activatable binding polypeptides and methods of identification and use thereof
09/24/2013US8541202 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein
09/24/2013US8541200 Cleavage of fusion proteins using Granzyme B protease
09/24/2013US8541191 Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids
09/24/2013US8541033 Production of human antibodies using NOD/SCID/γcnull mice
09/24/2013US8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
09/24/2013US8540987 Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody
09/24/2013CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/24/2013CA2486583C Marker molecules associated with lung tumors
09/24/2013CA2473922C Bacteria with reduced genome
09/24/2013CA2448427C Molecules and methods for inhibiting shedding of kim-1
09/24/2013CA2318857C Use of heregulin as an epithelial cell growth factor
09/24/2013CA2312478C G-protein coupled receptors and uses therefor
09/19/2013WO2013138512A1 OLIGOMERIC Aβ IN THE DIAGNOSIS, PROGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASE
09/19/2013WO2013138371A1 Methods for treating pancreatic cancer using combination therapies comprising an anti-erbb3 antibody
09/19/2013WO2013138351A1 Separatome-based protein expression and purification platform
09/19/2013WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF
09/19/2013WO2013136095A1 Peptide arrays
09/19/2013WO2013096291A3 Modified polypeptides for bispecific antibody scaffolds
09/19/2013US20130245234 Vmp-like sequences of pathogenic borrelia
09/19/2013US20130245230 Unnatural Reactive Amino Acid Genetic Code Additions
09/19/2013US20130244927 Polynucleotides encoding signal peptide-containing molecules
09/19/2013US20130244280 Expression vector for high level expression of recombinant proteins
09/19/2013US20130244279 Formulation and delivery of plga microspheres
09/19/2013US20130244278 Formulation and delivery of plga microspheres
09/19/2013US20130244277 Gene Expression Technique
09/19/2013US20130244276 Production of proteins in filamentous fungi
09/19/2013US20130244265 Secretion of recombinant polypeptides in the extracellular medium of diatoms
09/19/2013US20130244254 T1r hetero-oligomeric taste receptors
09/19/2013US20130244245 Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids
09/19/2013US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
09/19/2013US20130243789 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis
09/19/2013US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof
09/19/2013US20130243773 Recombinant production of mixtures of antibodies
09/19/2013US20130243768 Multimeric proteins and methods of making and using same
09/19/2013US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/19/2013US20130243731 Oncolytic adenoviral vectors coding for monoclonal anti-ctla-4 antibodies
09/19/2013US20130243728 Recombinant microorganisms
09/18/2013EP2639309A2 Membrane protein expression vector comprising a fusion partner consisting of the envelope protein p9 of cystovirus phi 12, and a membrane protein production method using the same
09/18/2013EP2639243A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
09/18/2013EP2639242A2 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
09/18/2013EP2638173A1 Fusion proteins comprising an engineered knottin peptide and uses thereof
09/18/2013CN1897969B Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 1125